SEC Info - Y-mAbs Therapeutics, Inc. - IPO: ‘S-1/A’ on 9/7/18

SEC Info℠

Home

Help

Please Sign In

Y-mAbs Therapeutics, Inc. – IPO: ‘S-1/A’ on 9/7/18

On: Friday, 9/7/18, at 12:37pm ET · Accession #: 1047469-18-6039 · File #: 333-226999

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/07/18  Y-mAbs Therapeutics, Inc.         S-1/A                  5:4.4M                                   Merrill Corp/New/FA

Initial Public Offering (IPO): Pre-Effective Amendment to Registration Statement (General Form) — Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML   1.67M 
                          (General Form)                                         
 2: EX-1.1      Underwriting Agreement                              HTML    217K 
 3: EX-4.1      Instrument Defining the Rights of Security Holders  HTML      7K 
 4: EX-5.1      Opinion re: Legality                                HTML     13K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML      5K

Filing Submission 0001047469-18-006039 – SGML Text

Original SGML Text submitted by:	Toppan Merrill-FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Y-mAbs Therapeutics, Inc. – IPO: ‘S-1/A’ on 9/7/18

On: Friday, 9/7/18, at 12:37pm ET · Accession #: 1047469-18-6039 · File #: 333-226999

Initial Public Offering (IPO): Pre-Effective Amendment to Registration Statement (General Form) — Form S-1Filing Table of Contents

To view the SGML, please refresh this page.

Initial Public Offering (IPO): Pre-Effective Amendment to Registration Statement (General Form) — Form S-1
Filing Table of Contents

To view the SGML, please refresh
this page.